Innovative Pricing and Payment Models for Health Technologies

By João L. Carapinha

October 22, 2024

pricing payment schemes

The article titled “Design and Features of Pricing and Payment Schemes for Health Technologies,” centers on the crucial topic of pricing and payment (P&P) schemes for health technologies in the healthcare sector. The discussion encompasses key aspects that influence this domain, providing insights on how these schemes can effectively address current challenges.

Objective

The article aims to map existing types of pricing and payment schemes for health technologies while proposing a new, flexible, need-driven classification system that enhances understanding and applicability.

Context

Given the increasing clinical and financial uncertainty in the healthcare sector, innovative pricing and payment schemes are being explored as potential solutions to these persistent challenges.

Current Schemes

The article conducts a scoping review to identify and categorize the various P&P schemes currently in use for health technologies. This includes different models such as:

  • Fixed pricing
  • Value-based pricing
  • Risk-sharing agreements
  • Pay-for-performance models
  • Subscription-based models

Proposed Classification

The authors propose a new classification system that is both flexible and need-driven. This system is designed to help policymakers, healthcare providers, and manufacturers navigate the complex landscape of P&P schemes more effectively. It considers various factors, including the type of health technology and the specific needs of different healthcare systems.

Key Features

The article highlights several key features of effective pricing and payment schemes, which include:

  • Flexibility: The ability to adapt to evolving healthcare needs and financial constraints.
  • Value-Based: Schemes that tie payments to actual health outcomes or to the value delivered by the health technology.
  • Risk Management: Mechanisms that distribute risk among manufacturers, payers, and providers.
  • Innovation Incentives: Schemes designed to encourage the development and adoption of new health technologies.

Implications

The proposed classification and analysis of P&P schemes have significant implications for healthcare policy, practice, and research. It can aid in:

  • Improving the sustainability of healthcare systems
  • Enhancing access to innovative health technologies
  • Aligning payments with health outcomes
  • Reducing financial uncertainty for various stakeholders involved.

In summary, the article provides a comprehensive framework for understanding and improving the design and implementation of P&P schemes in the healthcare sector, ultimately serving as a vital tool in addressing current challenges. The focus on pricing and payment schemes is essential for fostering effective health technology utilization and ensuring ongoing innovation.

Reference url

Recent Posts

large language models
Large Language Models in Evidence-Based Medicine

By João L. Carapinha

July 3, 2026

Large language models deliver rapid synthesis of medical literature, but according to research on fast information and slow evidence, they cannot independently generate validated evidence for clinical decisions. These tools sit at a...
African Pharmacogenomic Integration
African Pharmacogenomic Integration Enhancing Essential Medicine Prescribing in Africa

By João L. Carapinha

July 3, 2026

African Pharmacogenomic Integration has become an urgent policy priority, with evidence showing that more than 10 percent of essential medicines across Africa require genetically guided prescribing to prevent harm and improve outcomes in diverse populations. Current dosage guidelines for HIV, ...
pharmaceutical manufacturing affordability
Pharmaceutical Manufacturing Affordability as a Key to South Africa’s Local Production Goals

By João L. Carapinha

July 3, 2026

Pharmaceutical manufacturing affordability remains the decisive factor in South Africa’s efforts to build domestic capacity for essential medicines and vaccines. Government, industry and research leaders who met at the TIPS Development Dialogue on 17 June made clear that economic barriers to acce...